Drug Side Effects
Search
MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA
MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA
was reported 45 times
These drug classes are most commonly taken by patients reporting MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA:
#
Drug
Count
0
Programmed Death Receptor-1 Blocking Antibody [EPC]
22
1
Vascular Endothelial Growth Factor Inhibitor [EPC]
22
2
Kinase Inhibitor [EPC]
10
3
Tumor Necrosis Factor Blocker [EPC]
8
4
Platinum-based Drug [EPC]
6
5
Aldosterone Antagonist [EPC]
5
6
HER2/neu Receptor Antagonist [EPC]
4
7
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
4
8
Corticosteroid [EPC]
3
9
Nucleoside Metabolic Inhibitor [EPC]
3
10
CD20-directed Cytolytic Antibody [EPC]
2
11
Estrogen Receptor Antagonist [EPC]
2
12
Factor Xa Inhibitor [EPC]
2
13
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
2
14
Nonsteroidal Anti-inflammatory Drug [EPC]
2
15
Provitamin D2 Compound [EPC]
2
16
Vitamin C [EPC]
2
17
Bile Acid [EPC]
1
18
Calcineurin Inhibitor Immunosuppressant [EPC]
1
19
Calcium [EPC]
1
20
Folate Analog Metabolic Inhibitor [EPC]
1
21
HMG-CoA Reductase Inhibitor [EPC]
1
22
Hepatitis C Virus NS5A Inhibitor [EPC]
1
23
Histamine-2 Receptor Antagonist [EPC]
1
24
Insulin Analog [EPC]
1
25
Interferon beta [EPC]
1
26
Interleukin-12 Antagonist [EPC]
1
27
Interleukin-17A Antagonist [EPC]
1
28
Interleukin-23 Antagonist [EPC]
1
29
Nucleoside Analog Antiviral [EPC]
1
30
Osmotic Laxative [EPC]
1
31
Polyene Antifungal [EPC]
1
32
Proton Pump Inhibitor [EPC]
1
33
Vitamin B12 [EPC]
1
34
Vitamin D [EPC]
1
35
Xanthine Oxidase Inhibitor [EPC]
1